Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19 (2021)
- Authors:
- Autor USP: NICOLAU, JOSÉ CARLOS - FM
- Unidade: FM
- DOI: 10.1056/NEJMoa2105911
- Subjects: COVID-19; TROMBOSE; ANTICOAGULANTES; PREVENÇÃO DE DOENÇA
- Agências de fomento:
- LifeArc Foundation, Thistledown Foundation, Research Manitoba
- Ontario Ministry of Health, Peter Munk Cardiac Centre
- CancerCare Manitoba Foundation
- Victoria General Hospital Foundation
- National Heart, Lung, and Blood Institute, National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)
- New York University Clinical and Translational Science Award program
- National Center for Advancing Translational Sciences of the NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)
- European Union through FP7HEALTH-2013-INNOVATION: the Platform for European Preparedness Against (Re-)emerging Epidemics (PREPARE) consortium
- Horizon 2020 research and innovation program: the Rapid European Covid-19 Emergency Research response (RECOVER) consortium
- Australian National Health and Medical Research CouncilNational Health and Medical Research Council of Australia
- Health Research Council of New ZealandHealth Research Council of New Zealand
- Canadian Institutes of Health Research (Strategy for Patient-Oriented Research Innovative Clinical Trials Program)Canadian Institutes of Health Research (CIHR)
- U.K. National Institute for Health Research (NIHR)National Institute for Health Research (NIHR)
- NIHR Imperial Biomedical Research Centre
- Health Research Board of Ireland [CTN ]
- Breast Cancer Research Foundation
- French Ministry of Health [PHRC]
- Minderoo Foundation
- AmgenAmgen
- Global Coalition for Adaptive Research
- Language: Inglês
- Imprenta:
- Source:
- Título: New england journal of medicine
- ISSN: 0028-4793
- Volume/Número/Paginação/Ano: v. 385, n. 9, p. 790-802, 2021
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
LAWLER, Patrick R et al. Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19. New england journal of medicine, v. 385, n. 9, p. 790-802, 2021Tradução . . Disponível em: https://doi.org/10.1056/NEJMoa2105911. Acesso em: 31 jan. 2026. -
APA
Lawler, P. R., Golighe, E. C., Berge, J. S., Neal, M. D., Mcverry, B. J., Nicolau, J. C., et al. (2021). Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19. New england journal of medicine, 385( 9), 790-802. doi:10.1056/NEJMoa2105911 -
NLM
Lawler PR, Golighe EC, Berge JS, Neal MD, Mcverry BJ, Nicolau JC, Gong MN, Carrier M, Rosenson RS, Reynolds HR. Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19 [Internet]. New england journal of medicine. 2021 ; 385( 9): 790-802.[citado 2026 jan. 31 ] Available from: https://doi.org/10.1056/NEJMoa2105911 -
Vancouver
Lawler PR, Golighe EC, Berge JS, Neal MD, Mcverry BJ, Nicolau JC, Gong MN, Carrier M, Rosenson RS, Reynolds HR. Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19 [Internet]. New england journal of medicine. 2021 ; 385( 9): 790-802.[citado 2026 jan. 31 ] Available from: https://doi.org/10.1056/NEJMoa2105911 - Sex difference in patients with ischemic heart failure undergoing surgical revascularization results from the STICH trial (Surgical Treatment for Ischemic Heart Failure)
- Activated Clotting Time to Guide Heparin Dosing in Non-ST-Segment-Elevation Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention and Treated With IIb/IIIa Inhibitors Impact on Ischemic and Bleeding Outcomes: Insights From the TAO Trial
- Patterns of Long-term Thienopyridine Therapy and Outcomes in Patients With Acute Coronary Syndrome Treated With Coronary Stenting: Observations From the TIMI-38 Coronary Stent Registry
- Anticoagulation With Otamixaban and Ischemic Events in Non–ST-Segment Elevation Acute Coronary Syndromes: The TAO Randomized Clinical Trial
- Aneurisma Verdadeiro Gigante e Calcificado do Ventrículo Esquerdo: como Proceder?
- Effect of dapagliflozin on outpatient worsening of patients with heart failure and reduced ejection fraction a prespecified analysis of DAPA-HF
- Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)
- Comparison between two different local hemostatic methods for dental extractions in patients on dual antiplatelet therapy: a within-person, single-blind, randomized study
- Randomized, placebo-controlled phase 2b study to evaluate the safety and efficacy of recombinant human lecithin cholesterol acyltransferase in acute ST-segment-elevation myocardial infarction: results of REAL-TIMI 63B
- Predictors of subclinical carotid atherosclerosis in middle-aged women
Informações sobre o DOI: 10.1056/NEJMoa2105911 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
